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ABSTRACT




In clinical research it is very common to compare two treatments on the basis of an efficacy
variable. More specifically, if Χ and Υ denote the responses of patients on the two
treatments A and B, respectively, the quantity P(Y>X) (which can be called the
probabilistic index for the Effect Size), is of interest in clinical statistics. The objective of
this study is to derive an efficacy measure that would compare two treatments more
informatively and objectively compared to the earlier approaches. Kernel density
estimation is a useful non-parametric method that has not been well utilized as an applied
statistical tool, mainly due to its computational complexity. The current study shows that
this method is robust even under correlation structures that arise during the computation of
all possible differences. The kernel methods can be applied to the estimation of the ROC
(Receiver Operating Characteristic) curve as well as to the implementation of none-
parametrize regression of ROC. The area under the ROC curve (ARC), which is exactly
equal to the quantity P(Y>X), is also explored in this dissertation. The methodology used
for this study is easy to generalize to other areas of application.
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The objective of this dissertation is to study measures of efficacy. Starting with the specific
problem of comparing two anti-hypertensive drugs in a double-blind clinical trial, a
bootstrap kernel density estimate of the difference of these drugs is proposed. The
bootstrap confidence intervals of the proposed density are also computed. The study
demonstrates that this method is fairly robust even under dependent structures that arise
during the computation of all possible differences, on which some of the inference is
based. A survey of the existing methods of efficacy measurement has been included
highlighting the salient points and limitation of each method.
These methods are also utilized to study survival analysis, more specifically the
estimates of the survival function and the hazard function. A density based algorithm to
estimate the derivative of the receiver operating characteristic curve is introduced in this
study. An application of this method in discriminant analysis is explored here.
This dissertation also utilizes algorithms such as kernel density estimation, nearest
neighbor estimation and ROC regression and shows that they can be effectively adopted as
applied statistical tools in the area of pharmaceutical statistics.
In the context of kernel density estimation, bandwidth selection methods play a
crucial role. Literature reviews of such methods are included in reasonable detail. All the
bandwidth selection methods fall under a general class of problems that can be subsumed




Examples of these optimization include maximum likelihood estimation, likelihood
ratio test, Neyman-Pearson Lemma and optimization of the bias and the variance of an
estimator.
1.2 Background Information
Comparing two treatments with respect to a primary efficacy variable is a problem which
is commonly encountered in the clinical studies. Several parametric and reparametrized
methods are used to find solutions to this problem. Parametric approaches are often based
on normality assumptions. reparametrized approaches are primarily rank based tests like
the Wilcoxon-Mann-Whitney(WMW) test.
Effect size (ES) presents the magnitude of the difference between two treatments
under consideration. In many of the recent approaches, ES is presented as a mathematical
expression, not easily understood by clinicians. An ideal ES measure is somewhat easy to
compute and appeals to both clinicians and statisticians. An example of such a measure is
given by the probabilistic index P (Y > X) , where B and X denote the performance
measure of two competing drugs (one of which may be a placebo). Here it is assumed that
the larger the performance value, the more efficacious is the drug.
One of the first studies that surveyed the estimation of the quantity P (Y > X) is
Wolfe and Hogg (1971). They have considered the estimation under the normality
assumption as well as without this assumption. Confidence bounds for P (Y > X) and
some related quantities is also explored with several examples.
Simonoff et al. (1986) have explored the quantities P (Y > X) and a reparametrized
version P (Y > X) — P (X > Y) in categorical data coming from two populations. In this
paper they have introduced a hybrid estimator with parametric as well as a reparametrized
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properties. This estimator is essentially Wilcoxon-Mann-Whitney (WMW) statistics, except
the proportions are calculated using normality assumption. They have also introduced in
this same paper, a smooth estimator of P(Y>X) — P(X>Y) based on non-parametńc density
estimation procedure. They have also shown both with empirical studies and theoretical
justifications by variance estimation and asymptotic results, that the hybrid estimator,
pseudo-MLE as they call it, gives accurate results under many circumstances. Note that the
smoothed estimator based on non-parametńc density estimation method has been used in
categorical data. Their study gives evidences that this estimator is asymptotically
equivalent to the BMW statistics and bias correction methods and bootstrap treatment
makes it even more attractive as a (bias reduced) smooth estimator.
Methods based on bootstrap confidence intervals of this quantity have been
discussed by Chen and Kianifard (2000). It has been correctly pointed out by them that the
rejection of the Wilcoxon-Mann-Whitney test would imply that the two distributions
underlying the observations are not the same. Therefore, in an efficacy measurement
analysis, it can be reasonably inferred that one treatment is better than the other. However,
this does not provide a quantifiable measure of efficacy. Also, it is mentioned in the paper,
and illustrated with an example that it is not reasonable to assume a shift model when the
responses are categorical. The Wilcoxon-Mann-Whitney test is often used with a shift
model assumption.
Contrast comparisons between several ES measures have been discussed by Action
et al. (2006). They have considered the commonly used `measure of separation' between
two distributions (Coven's d), as one of the meaningful ES. However, the limitation of the
'Coven 's d' lies in it's assumption of homoscedasticity, which is often not the case. The
Odds ratio and the generalized odds ratio are also explored in the above mentioned paper.
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The quantity P (Y > X) or the probabilistic index is introduced as one of the competitive
ES measures in this paper by Action et al. (2006).
Although this probabilistic index was in use before, the close relation between the
Receiver Operating Cvaracteristics (ROC) curve and the quantity P (Y > X) has
generated renewed interest in clinical research in a paper by Action et al. (2006). The
'Kendal's τ' is also discussed in the above paper, but this is only meaningful if the data is
collected in matched pairs. Brumback et al. (2006), have also developed methods of
connecting the probabilistic index with the ROC and introduced the Area under tve ROC
Curve (AUC). The most involved part of their work is on accommodating for covariate.
Adjusted ARCH is an alternative index for the AUC which is computed on the basis of a
semi-parametric grouping of the covariant measures which works even in difficult practical
situations like confounding effects. AUC Regression is also mentioned in the same context.
This topic is developed in detail by Dodd and Pepe (2003) and Pepe (2003).
Asymptotic approaches towards the effect size measure problems are considered by
Newcombe (2006). Tail area based methods of determining efficacy is the prime focus
there. Several competitive methods are discussed and a final choice is recommended on the
basis of the performance comparison of these methods in the above mentioned paper.
ROC as a concept is borrowed from the signal detection theory. It is in use in the
context of medical diagnostic testing for evaluation of the performance of a binary
classifier with continuous output.
There is a fairly extensive literature on estimating P (Y > X) where X, Y follow
two unknown distributions F and G, respectively. While the interest lies in estimating this
quantity P (Y > X) , a comparatively new way to approach this problem and draw
inferences is to consider the amount of the shift D (= Y — X) of the random observation
5
vectors X and Y. Here D itself is a random variable.
parametric density estimation is a novel method which has been overlooked for
a long time by clinical statisticians. Parametric density estimation however, is commonly
used by statisticians. For example, if D is normal, one would only have to estimate the
mean (μ) and the variance (σ 2 ) from the data. Alternately, if the density of the quantity D
is Gamma, one would try to estimate the scale and the shape parameters α and λ of the
gamma density.
Nonparametric density estimation is a general method to deal with unknown
densities. This method works with minimal assumptions. No assumption of a specific
density or even a family of distributions (location, scale, exponential family et al.), is
required in this method.
This approach can be well adopted in this context. Instead of dealing with the
individual densities of X and Y one can deal directly with D and look at the above
mentioned quantities as the following:
In the current study, Nonparametric density estimation methods are applied for
estimating the quantity 00 . Along with it, estimates of P (D > v) is obtained for many
threshold values v. More on this would be given in the density estimation chapter.
Apart from the Nonparametric density estimation, parametric approaches also have
a great potential if explored in problem specific modeling. For example exponential,
ό
double exponential, gamma, uniform or generalized uniform assumptions lead to the
corresponding Uniformly Minimum Variance Unbiased Estimate (UMVUE) of PAY> X )
and inferences related to it (Ali et al. , 2005).
CHAPTER 2
NON-PARAMETRIC RESULTS
In this chapter the original problem, the study of two antihypertensive drugs will be
described in detail. The relevance of the nonurparametric density estimation methods and
their application to this problem will also be pointed out. Different density estimation
methods will be considered with the problem in the foreground. Survival analysis
methods and receiver operating characteristic curves are very closely related to
nonurparametric density estimation, mainly because the same algorithms that work for
estimating the density potentially helps to come up with estimates of hazard functions
(failure rates), and receiver operating characteristic curves.
2.1 Defining the Problem
The following data (Table 2.1), on a doubleurblind clinical trial to compare two
antihypertensive drugs was obtained from Hogg et al. (1990) and Chen and Kianifard
(2000). The primary efficacy variable is the change in blood pressure from the baseline,
i.e. difference of the blood pressure reading after the treatment with the drug from the
blood pressure reading before the treatment. Most of the analyses in this kind of problem
either assume normality, and involve an unpaired turtest, or with minimal assumptions,
use a nonurparametric version of this t-test, namely the WilcoxonurMannurWhitney (BMW)
test (also called the MannurWhitney U test).
The BMW tests are rank based tests, called the Wilcoxon rank-sum test and the
MannurWhitney U test introduced independently by Wilcoxon (1945) and Mann and
Whitney (1947). The purpose of these tests is finding out if the two random variables has
the same distribution, or if one of the random variables is stochastically larger than the
7
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other. Detailed discussions of these tests along with similar rank based tests are included
in Lehmann (1998). Some of the studies combine the two tests as the Wilcoxon-Mann-
Whitney (BMW) test. However, the BMW test is often used where two population
distributions are assumed to have the same general shape, but one of them is shifted
relative to the other by a constant amount Δ , under the alternative hypothesis. The
computational aspects of the WMW test statistics have been reviewed by many
researchers, Bernhard et al. (1988) and Ludbrook (1995) have examined the accuracy of
the BMW test in microcomputer statistical packages. Bergmann et al. (2000) have
reviewed the performance of the BMW test with 11 commercial statistical packages.
They have used real datasets from a pharmacological experiment and found that these
commercial statistical packages gave very different outcomes from the Wilcoxon-Mann-
Whitney test. The popular ones in their list of 11 packages include SAS 6.12, Surplus
2000, SASS 8.0, JIMA 3.2.5 and SYSTAT 9.
In Chen and Kianifard (2000), they have considered the efficacy measure 00
given by
Table 2.1 Distribution of Blood Pressure Change from Baseline for
Two Antihypertensive Drugs
[Source: Chen and Κianifard (2000), Hogg et al. (1990)]
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The dataset given in Table 2.1 will be repeatedly used in the present study. A
summary statistics of this dataset is included in the Table 2.2 to give a rough idea of the
data, so that the reader would be prepared for the different analyses performed at a later
point in this study.
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Table 2.2 Summary Statistics
It has been pointed out in Chen and Kianifard A2000), that PAY> X) is
equivalent to the Wilcoxon urMann-Wvitney statistic in continuous data. Α bootstrap
confidence interval for the above parameter Γο has been computed in this paper. It has
also been mentioned there that the BMW statistic does not give us a quantifiable measure
of efficacy. Generally speaking, looking at the critical values of the Mann-Whitney Rur
statistic or deriving a confidence interval of the above mentioned parameter Γο would
give us the much needed insight of the efficacy. It would also make it clear to us if the
medians of the two distributions in question are significantly different, under the shift
model assumption. The information that it would fail to provide would also be vital. For
example it would not be able to give us information on the underlying uncertainty of the
two distributions or a quantifiable difference of the means of the two distributions.
Studies show that the Mann-WhitneyurU statistic can be unreliable if the variances of the
two populations are quite different. It also has the drawback of ignoring any information
obtainable from the underlying distributions; see S Simonoff A1986), Owen et al. A1964) or
Birnbaum and McCarty A1958). Potthoff A1963), has introduced a modified form of the
Wilcoxon statistic to test broader form of null hypothesis that involves unequal variance
and absence of normality, which is commonly referred to as the BehrensurFisher problem.
'Coven 's d' is a nonurparametric measure of effect size, commonly used in
psychometrics and other areas of applied statistics, and particularly in problems that have
similar structure as the one cited above. It is given by the following formula
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where Y and X are the respective means and Sp is the pooled standard
deviation. S ly and S2 are the standard deviation of the two samples of sizes ni & n2,
respectively. The advantages of working with this measure is that it is not based on
distributional assumptions and is unit free, so it is easier for nonurstatisticians to
understand the effect size just by looking at the prescribed limits, for example, 0.2 for
small effect size, 0.5 for moderate and 0.8 for high effect size (Action et al., 2006). These
limits cannot be statistically meaningful.
However, it is easy to show that with unequal variances `Coven's d' is not a
meaningful estimator of effect size. It is easy to upset the measure and have Cohen's d'
values smaller than 0.2 and yet have quite a separated pair of populations. For example,
in the following summary statistics, the `Coven's d' is smaller than the prescribed 0.2,
but the means are far apart:
Table 2.3 `Coven's d' Values for Different Ratios of Means of Two Samples
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The `Coven's d' value is given by 0.194 (< 0.2) and yet one can readily see that
the effect size should be far more than moderate. Given in Table 2.3 are the `Coven's d'
values for different ratios of the means, keeping the remaining relation same as the
present example.
To get even a small effect size, the mean of one sample has to be at least about 5
times bigger than the other. The standard deviation of one sample being 23 times bigger
than the other plays a key role in explaining the level of the effect size.
Consider the primary efficacy variable of the two drugs in question. In this case it
is the change in blood-pressure after administering the drug. Note that the pair of
variables may come from two different distributions, defined on the same domain, but
possibly with different variance, shape and structure. That is, the probability densities of
both these variables would have all the positive mass in the same subset of the real line.
Additionally, they are independent of one another. The test of equality of means under
these general assumptions of unequal variance is quite involved when normality is not
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assumed; this is referred to as the Bevrens urFisver Problem.
Even if it is known that the mean or the median of one treatment is bigger than the
other, one would still be unsure of the answer to the question "how much bigger ?". This
question is the key focus for the measure of effect size. Consider two samples from two
different populations. The observations from these two populations are independent of
one another, both within and between the samples. If the study is in matched pairs, one
can define D to be the vector of pair wise difference. The situation now deals with a pair
of independent samples and additionally, they may not be of the same size, although in
this example, the sample sizes are the same. If one could look at the vector D of all
possible differences, they are draws from the distribution of the true difference. Note that
they are identically distributed as F, the theoretical distribution of the differences, but
they are not independent, as the cohort of the difference values would be correlated with
each other. The density computed from the differences in the vector D would not only
provide the shape of the difference, it would also provide estimates of the median and
other quintiles, mean and the variance and can be utilized to get the estimate of the
derivative of the density. It would also give a clear idea of the amount of separation of
the two distributions. Application of bootstrap procedure helps in the removal of bias. At
this point, it should be noted that BMW statistics itself is computed in a way that
introduces the same cohort of dependence and yet the result is unbiased as it can be
shown that it belongs to a larger class of symmetric statistics, namely the statistics.
Given a pair of vectors of observed values from the two distributions, one can
look at the differences from all possible combinations. Thus, the difference D is denoted
by AY - Χ) which is the abbreviation for Dmnx1 = ADii, D12, , Dmη )T where Υ and X are
two vectors of dimensions n x 1 and m x 1, respectively, and D;; = Υ; — Χ, .
14 .
Mann - Wvitney U is an unbiased estimator for the parameter Θ^ which is defined
as
For continuous distributions, it reduces to
Note that the definition of Bo for the non-contiguous distributions involves the
additional term 1 P AY = X ). This term is introduced to adjust for ties in the sample.
2
However, the added term 1 P AY = X ), ensures that the information of ties is used and is
2
consistent with the expression of incremental probability given by the following
expression
The Receiver Operating Cvaracteristic curve applied in the context of efficacy
measurement is also another appealing area of study, more so because of the relationship
of the area under this curve and the following quantity P AY > X ), the probabilistic
measure of effect size.
2.2 Density Estimation Methods
Assuming that the distribution has a continuous derivative, density estimation procedures
can be applied with minimal assumptions. Let the density of FD exist. The density
estimation procedure helps in visualizing the separation between the two treatment
distributions. The estimate captures the shape of the true density.
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Densities can be computed using various non-parametric methods such as
vistogram, kernel density estimation, maximum penalized likelivood estimation, the
nearest neigvbor metvod et al. Kernel methods can be based on several different kernels,
with contrasting properties of the candidate kernels. Adaptive and variable kernel
methods are popular in different statistical applications.
Apart from the choice of kernels, there are several methods of choice of
bandwidths in kernel density estimation. However, different combinations of choices of
bandwidth and kernels lead to estimated densities with different shapes and properties,
often inherited from the kernels used for estimation. In addition, depending upon the
choice of penalty functions, selection of kernel and bandwidth can be affected.
Fortunately, the estimation procedure is relatively insensitive to the choice of kernels but
is sensitive to the choice of bandwidth.
The most popular method of estimating densities is the histogram method.
Although this method is intuitive and easy to follow, and perhaps the most widely
accepted one, however, it suffers from some serious drawbacks. The most important
one is the shape of this density, which can depend heavily on the chosen bin-widtv and
the number of bins. Also, the histogram is just a collection of boxes stacked over one
another representing the frequency or the relative frequency of the bins. However, the
target density may be absolutely continuous and may have derivatives of many or all
orders. Thus, a histogram density estimate may not capture some fundamental aspects of
the underlying structure. The average shifted histogram AASH) does rectify most of the
problems encountered by the ordinary histogram approach. See Silverman A1986) or Scott
A1992) for a detailed discussion.
The kernel density estimate, on the other hand, depends on the choice of kernels
and the bandwidths. The underlying shape of the density estimate does not change much
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with a reasonable choice of bandwidth. However, the wider this bandwidth, the smoother
will be the shape of the density. Too small a bandwidth shows an overly rough curve, and
too wide bandwidth can smooth out the important details from the shape of this density.
2.3 Survival Analysis
Hazard rate or failure rate is commonly used in survival analysis. It is defined as:
where fAt) is the density function and FAt) is the cumulative distribution function. Note
that if the random variables Y and X have proportional vazard rates, and the constant of
proportionality is c, that is, if the following relation hold:
This is a nonurparametric property. However, a similar property holds under a weaker
condition, which does not assume the density.
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Hence an inference based on the proportionality constant c is in fact directly
interpretable as inferences on P AY > X ). Existing reliability tests like log-rank test have
been developed to draw inferences on this constant of proportionality.
2.4 Receiver Operating Characteristic Curve
Receiver Operating Characteristic AROC) curve borrowed from the signal detection
theory is very closely related to the ES. Α point on the ROC curve can be expressed as
Where Y > c indicates classification into the class of
Here ° and ι denotes diseased and healthy populations, respectively. See Dodd and
Pepe A2003) for a comprehensive discussion on this. The curve is constructed by joining
different points based on decreasing threshold c, although the exact value of c is not
represented on the curve. By definition, the range of the curve is [0, 1] x [0, 1] . From the
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point of view of ROC curve in the context of ES we would denote PAYE > c 1 c) as
Ρ(Χ > c) . That is, observations originally from the 	 class are denoted as Χ .
The empirical ROC curve can be obtained from a pair of data vectors simply by
plotting the empirical survival functions of the two random variables. Hence the
empirical ROC curve may take different shapes based on different sample observations.
Examples of ROC curves with illustrations are included in the simulation section. Given
in Figure 2.1 is a plot of a ROC curve of two populations, diseased and normal, where the
horizontal axis represents the normal population.
Figure 2.1 ROC curve.
Methods similar to the ones used in non-parametric density estimation can be
applied to estimate the theoretical shape of the ROC curve. Although there is an
increasing popularity of the usage of the ROC curve in fields like radiology and clinical
statistics, not many researchers have explored the density estimation approaches in this
context.
Area under tve ROC curve (AUROC), as the name suggests, is the quantity
obtained by measuring the area under the ROC curve. It is easily checked that AUROC is
theoretically equal to the ES.
Hence, any inference based on AUROC is exactly equivalent to that based on ES.
Estimates for the ES may also be obtained by the direct approach. This is going to be one
of the primary focuses of the approaches of this study.
CHAPTER 3
PARAMETRIC RESULTS
Nonparametric ideas help us when no parametric assumptions seem to be satisfactory or
even valid. But in the presence of known distributions with certain unknown parameters
it is possible to find UMVU of the ES. This problem is solved exactly the same way as
one would solve a UMVU problem in the parametric set up. Ali et al. (2005) have
attempted to solve this problem under the assumption of Generalized Uniform
distribution, and successfully found UMVUE estimates of 8= P (Y > X) and also of
8k = { P (Y > X) } k , where Γ is called the reliability measure. They have discussed
examples of statistical tolerance in the context of diameters of bearings and shafts.
Generalized Uniform would be a good choice in this context, but in clinical
efficacy and related applications, the exponential family of distributions, particularly the
exponential distribution seems to be more appropriate. Assuming a general class of
distributions such as the exponential family would lead us to Nonparametric ideas,
while special cases like normal distributions with known variances and exponential
distribution, or the gamma distribution with the known scale parameter looks promising.
3.1 Exponential UMVU for ES
Estimation of the quantity P (Y > X) in the exponential distribution has been covered by
many researchers. Estimation of P (Y > X) where both X and Y have double exponential
distribution is covered in Pal et al. (2005). In the preceding paper, double exponential
distribution with a known scale parameter and unknown location parameter has been
considered. The exponential distribution is a very attractive choice because of the
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memoryless property and several other interesting properties such as the characterization
based on absolute difference (Puri and Rubin, 1970). Scathe and Shah (1981) have
explored the lower bound of the variance of the estimator of P (Y > X ), where Y and X
are distributed exponentially with parameters λ and μ . They have also explored the
bound for the Mean Squared Error of the Maximum Likelihood Estimator when one of
the two parameters λ and μ is unknown.
There are several other studies on the same subject that makes it evident that
estimating P (Y > X) in the exponential setup is indeed a popular problem. Examples of
these studies are Ivshin (1996), Cramer and Camps (1997), Ali et al. (2004) and McCool
(1991). The following result is derived assuming the exponential distribution for two
random variables. The theoretical value of ES is denoted by B .
unbiased estimator of B , conditioned by the complete sufficient statistics would be the
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UMVU estimator. We will show that the following unbiased estimator of P (Y > X )
would serve the purpose: I (Y > X 1 ) where
Hence, this estimator would be given by the following expression
Note that Al and X 1 are conditionally independent of each other. In other words,
Al 1 s, it is independent of X i 1 s, t , which would be clear from the following derivation
Thus, it can also be viewed as the mean of a fraction, involving a binomial
random variable.
Note that both forms of the UMVU estimator are valid for m >_ 2.
To study the finite sample properties of the UMVU estimator along with the MMLE
estimator, Ionte Carlo simulations are performed with a range of values of λ 1 and λ 2 .
The sizes of the samples drawn from the two exponential populations are taken to be 300
and 400. Five thousand Ionte Carlo simulations are done in each case. The estimates are
given along with the mean squared errors (MMSE) in Table 3.1. The MSE values for the
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MALE estimates are comparable to the ISE of the REVUE. Since the ILE is easier to
compute, and the UMVU estimator does not give an added advantage over the ELE as




Cernel density estimation can be realized as the limiting process of the average svifted
vistogram (ASH) approach. Virtually all nonparametńc density estimation algorithms can
be shown to be asymptotically a kernel method (Scott, 1992). The General Kernel
Tveorem due to Terrell and Scott (1992) establishes this.
Given a distribution function F, the density can be written as
indicator function in the equation above, one can use a kernel function K ( .) and arrive
at the Cernel density estimator.
This kernel estimate of the density function can be written as
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This is the basic idea of kernel density estimation.
The kernel density estimator as mentioned above is also called the Parzenurur
Rosenblatt estimator, with a chosen kernel function K (.) defined as F(A) described
above.
Here n is the number of observations X i through X n . Although, they are
supposed to be independent observations from the same distribution, the kernel method is
often used when this assumption is violated. Here v is called the bandwidtv or the
smootving operator. It is essentially the half length of the window in which the
smoothing takes place.
For detailed descriptions of density estimation one can look at any of the
following resources, Scott (1992), Handle et al. (2004), Silverman (1986), Azzalini
(1981), Seheult and Queseriberry (1971) and Denman (1988).
The kernel density estimator is a combination from the kernels applied to each
evaluation point. Thus the estimators inherit the properties of the kernels. This
phenomenon is graphically expressed in the diagram (Figure 4.1). The densities given
there are computed for the data on antihypertensive drugs, the example introduced in
Chapter 2. The kernel functions are enlarged by a scale of ten, to enhance the visual
effects.
Τ1	 • 	 1 	 1 	 .. 	 1 	 1• 	 • 	 1 	 1 	 ,1 	 • 	 1• 	, 	 .,
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the number of observations falling into that bin is counted. Each of these observations is
given equal weight and that yields the rectangular histogram. In kernel density
estimation, a similar approach is taken and an interval of the length twice as much as the
bandwidth is taken around a typical evaluation point. The observations falling into that
interval are utilized to construct the kernel estimate and a weight is assigned to the point
in such a way that the point closest to the center gets the highest weight and the point
furthest from the center gets the lowest weight. This phenomenon is explained
graphically in the diagram (Figure 4.2).
Some of the popular choices of kernels are given in Table 4.1. While evaluating
the performance of the kernel density estimator, it is important to choose an appropriate
loss function that will be able to compare the fitted density over the whole support. An
expected loss function, known as the risk, can be calculated by averaging over all
possible loss values. Mean Integrated Square Error (MISS) is one such choice and the
compared to any arbitrary kernel function (Silverman, 1986). The symbol Keg represents
the Epanechnikov kernel. It has been well established that under the assumption of
independence, the Epanechnikov kernel outperforms most of the symmetric kernels as far
as efficiency is considered. See Silverman (1986) for more information.
Table 4.1 Choices of Cernels
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Although there are relatively few studies on the efficiency of kernels for
dependent data, the independence assumption is often violated in real life problems and
yet most of the properties of the density estimators still hold. Hall et al. (1995) have
shown that even in a strongly dependent data sequence, asymptotically optimal
bandwidth for independent data is a good choice, as long as some regularity conditions
(such as existence of the sixth derivative of the true density) are satisfied. In this same
paper they have also shown that the MISS expression for the dependent sample has a
similar form as the MISS expression for the density estimate from an independent
sample. A typical chart of the efficiency of other kernels compared to the Epanechnikov
kernel is given in Table 4.2.
Table 4.2 Efficiencies of Cernels Compared to Epanechnikov Kernel
(Source: Silverman, 1986)
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Figure 4.3 UUnivariate kernel density estimates of the effects of two blood pressure
lowering drugs along with the Epanechnikov kernels at the evaluation points using
bandwidth =4 and 5.
Given in Figures 4.3 , 4.4 and 4.5 are the plots of UUnivariate density estimates of
the blood pressure values using different bandwidths and the Epanechnikov kernel. The
bandwidth is the smoothness parameter. The larger the bandwidth is, the smoother the
curve. If the chosen bandwidth is too small, it might generate spurious roughness into the
density. On the other hand, if chosen bandwidth is too large, it would smooth out the
curve beyond an optimal amount. Thereby it would introduce bias into the density
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estimation procedure. The smoothing criterion can be illustrated using larger bandwidth
with the same set of data points.
Figure 4.4 Univariate kernel density estimates of the effects of blood pressure lowering
drugs along with the Epanechnikov kernels at the evaluation points using bandwidth =9
and 12.
Consider the example in Chapter 2. The set of all possible difference from the
data on bloodurpressure drugs is 3481 (which is 59 squared). Even with this huge volume
of data, it can be seen that with a small bandwidth, a rough spot would surface. For the
same example, if densities are computed separately, the same phenomenon will surface.
The illustration of this is given in the Figures 4.3, 4.4 and 4.5. The chosen bandwidths in
these Figures along the first and second rows are (4, 5), (9, 12), (15, 20) respectively.
That is, the first row in the Figure 4.3 corresponds to a bandwidth of 4 and the second
row corresponds to bandwidth of 5. The general notion is clear from these diagrams, the
density estimates become rough, smoothed and overursmoothed with the use of larger and
larger bandwidth.
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Figure 4.6 Univariate kernel density estimates of the effects of two blood pressure
lowering drugs using several kernels and the same bandwidth.
In the Figure 4.6, the density plots corresponding to the kernels are color-coded
for comparison. When different kernels are chosen keeping the bandwidth fixed, the
estimates do not vary too much. This plot would somewhat illustrate this. Here seven
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kernels are used for the smoothing operation and the estimated density of the difference is
plotted in the same figure.
To investigate these density estimates with varying choice of kernels, an
experiment is conducted with the same dataset, namely the variable D. density estimation
results using same data and different kernels are given below. This further illustrates the
fact that choice of any of these functions as kernel functions make little difference in the
overall estimation method.
Table 4.3a Comparison of Density Estimates for Different Cernels Using the Same
Bandwidth of 10.5
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The kernel function usually chosen satisfies the following properties:
The asymptotic distribution of the kernel estimator regardless of the chosen kernel
is given by : N(f (x) + βλ , σ2 ) , where f (x) is the true density and the other constants
are given by:
Note that the bias factor fax  depends on the chosen kernel as well as the bandwidth
(v) and the second derivative ( f (2)) of the true density evaluated at the point x.
Therefore, minimization of bias would involve appropriate choice of the kernel and the
bandwidtv.
But this choice of the kernel and the bandwidtv would affect the value of σ .
Hence the goal would be to find optimal kernel and bandwidtv to minimize both bias
factorβX and variance σ . The convention is to minimize the Integrated Squared Error
('SE), mean integrated square error (MISS) or the approximate formula for the MISS
(AMISS).
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There are other forms of loss functions that would lead to different type of
optimal bandwidtv. One such example is the Kullback-Leibler information given by:
where K is the kernel function and μ2 is the second order moment with respect to
the kernel function, and f is the true density. Different combinations of loss functions,
kernel functions would give different optimal choice of bandwidtv and hence different
density estimates.
Taylor (1989) has explored the optimal choice of smootving parameter
(bandwidtv) using bootstrap. Instead of computing the integrals for the discussed loss
functions, he used the bootstrap mean and bootstrap approximations for integrals. He has
shown that the optimal choice of bandwidth for this method coincides with the optimal
choice in kernel density estimation.
Zhou and Hareziak (2002) have compared several bandwidth selection methods in
kernel smootving of ROC curves. Their empirical studies show that the Altman smootving
metvod performs best amongst the ones compared.
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4.2 Estimation from Dependent Data
Kernel density estimation method is applied on data that are assumed to be independent.
Dependent datasets appear naturally and therefore are often used to estimate the density.
As a result, estimates that are inferior in terms of larger variance are obtained. If the
nature of dependence is known, then an improvement can be expected in terms of lower
variance, or at least a better bound of the possible bias and variance can be obtained with
this extra knowledge of the dependent structure. Hence methods for reducing the bias or
the variance can be adopted to further improve it. Thus, it is always important and useful
to know if the datasets is dependent, and if it is what is the nature of such dependence.
When density estimates are computed from all possible differences of the two
efficacy variables from independent samples, only the variance of the estimate
deteriorates, and the bias remains unaffected. The asymptotic properties of the estimates
such as normality, reduction of bias (slow) witv increased sample size, remains to be as
attractive as before. If the exact expressions of the covariance between the kernelsur
smooched variables are known then one can come up with even stronger results. This is
summarized and proved below.
New Result 4.2.1 Let X i , X 2 , .... X m and Al , A2 , .... An be independent samples
from two unknown distributions EX and FY assuming continuous densities fa and
fl, respectively. Let Al  , A2 , .... WM  be the list of all possible differences of X and A,
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generalized Hoeffding's theorem, or the generalized Rurstatistics. For more detailed
discussions on the generalized Rurstatistics see Lehman (1963).
Result 4.2.2 In the above set up, let f,,, be the true density of the random variable
the bandwidth used and μ2 is ιι 2 K(t) dt .
The expectation is exactly equal to the expectation of the density estimate
obtained using independent data. The reason of equality is the well known fact that even
in the case of correlated random variables the sum of expectation is the expectation of the
sum.
(using the fact that the M random variables, although dependent, are certainly identically
distributed). This can be written as the following expression
Now let x v B = —t, hence B = x + vt and dB = vdt. Then, the above
)
expression becomes the following quantity (Note that F(.) assumes continuous
density fa  , which is being estimated).
Recall that the density estimate computed from the dependent data performs
almost as well. It has all the nice return asymptotic properties, and normality. The bias
function is also equal to the one obtained in the case of independent data. The general
belief is that the bandwidth selection methods that work for independent data are not
quite applicable in the case of dependent data. However, there is a relevant work by Hall
et al. (1995) addressing the method of bandwidth selection in the context of density
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estimation from dependent data. In this paper referred above, they have shown that even
in strongly dependent data sequences, the asymptotically optimal bandwidth computed
with the independence assumption is a ged choice. As a matter of fact the secondary
dependence induced by the kernel function applied on the dependent data structure has
got stronger influence than the original dependence according to this paper.
The structure of dependence in the scenario described above can be formulated
with the covariance matrix given in the following display. Let the covariance matrix of
the m x n data points obtained from all possible pair wise differences be denoted by Σ .
Here Dij 's are V1 — Χ ; (i = 1, 2, ... , m and j =1, 2, ..., n ) and thus they are
identically distributed, although they are not necessarily independent. Further denoting
the matrix Σ.Χ. can be written as the following expression
By some simple manipulations, the above matrix Σ 	 can be written as
Here O denotes the KKronecker product of matrices, I denotes the identity matrix of order
m x m , J denotes the m x m matrix with all the entries equal to unity, Ρ 1 and P2 denotes
the matrices given below:
If the estimate of these quantities σα , σα and σ2 are available, then one can
easily estimate Σ .
Α closed form expression of the inverse of the covariance matrix can be obtained
following the result of Miller (1981). This expression in turn can be used to compute the
this route comes to a dead end because of the following two reasons. Without
assumptions about linear combination of the true density falling into the same family of
density, this approach cannot be used effectively. In addition, one cannot expect
uncorrected sample to be independent. Only exception for both these restrictions is when
the data are random samples from the normal distribution.
4.3 Simulations
An experiment with known densities, conducted in the context of density estimation from
independent data is given below. The goal of this experiment is to see how the density
estimates computed from a dependent and independent data compare with each other.
Based on the theoretical results discussed in the preceding section one can expect
comparable results from the two kinds of estimates. Thus estimate from a completely
random sample is kept as a benchmark to judge the performance of the estimate from a
dependent sample, where the dependence is artificially introduced keeping in mind the
study of two drugs discussed in chapter 2. Wherever available, the true density is used in
the experiment.
The independent data are sampled from a Ν(1, 2) population, the dependent data
are obtained from two independent samples of N(0,1) and N(1, 1) population. In this
of the difference of the two normal populations N(0,1) and N(1,1) is also the same. To
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cross compare the performance of the two density estimators, the true density is also used
in this experiment.
Table 4.4 Comparison of Estimated Mean Integrated Squared Error of Densities
Computed from Independent and Dependent Data
The MISS along with the sample size used in the density estimations is also
given. In this estimation, the Epanechnikov kernel is used and biased cross validation
method is used for the selection of asymptotically optimal bandwidth. The MISS is
calculated using the following expression:
This method of MISS is described in Seaman et al. (1996). Here ](x) and fax)
are the estimated density and the true underlying density respectively. The number n is
the number of evaluation points of the densities, which is chosen to be either 512 or 1024.
The range of the x values chosen for the density estimates are between -8 and 8, to ensure
the inclusion of all the probable sample from each of the true underlying densities.
The independent density estimates are calculated using N number of data points
where N varies from 200 to 300. On the other hand, the dependent density estimates are
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calculated using all possible difference of two Normal samples, each of size 100 to 150.
These numbers are exactly half of the sample sizes taken for the independent density
estimate. Thus there are N number of dependent data points and just like in the
4
previous case, N varies from 200 to 300. Interestingly, it is observed that the density
estimates corresponding to the dependent data are by far a lot better than their
independent counterpart. The Table 4.4 illustrates this finding.
MISS from deep & End data
Figure 4.7 Mean integrated squared error (MISS) comparison of the density estimates
computed from an independent sample and a dependent sample.
The MISS values computed from density estimates based on independent data,
along with their counterpart (density computed from dependent data) are given in Figure
4.7. To keep them on the same scale, the MISS from dependent data is multiplied by a
factor of 200. Bet the pairurwise MISS values for sample sizes 200 through 580 seem to
be comparable.
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Hence if the cost of sampling is a constant, then the simulation clearly shows that
the density estimation from the dependent dataset performs better than the independent
set, because in both the cases we sample the same number of variables, N and 2 x N .
2
In Figure 4.8 a single instance of the density estimate for N = 250 is given along
with the true density and the dependent density computed from the pair of normal sample
each of size 125.
density estimates compared with the real density
Figure 4.8 Density estimates compared with the true density.
However, one can correctly point out that the estimates computed in the case of
2
independent dataset are based on Ν data points, whereas there are N x N = 
N data
2 2 4
points (a far larger number), used in the estimation from the dependent set. Hence,
overall precision in the dependent case might be lucrative but the `per unit precision' may
not be comparable. Interestingly, even the following experiment shows quite satisfactory
result.
with the estimate obtained from the independent sample and the actual density N(1,2).
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datapoints
Figure 4.9 Density estimates from a very large number (40,000) of independent
observations.
In Figure 4.9, the reported density estimate from the dependent data is computed
from a pair of independent samples of size 200. Thus the artificially generated sample has
a size 40,000. This is exactly equal to the size of the independent sample drawn from the
N(1,2) population. Note that both the density estimates computed from dependent and
independent data performs very good.
Recall that the density of D (difference between two drugs with respect to the
primary efficacy variable) has been computed from the dependent data. It has also been
mentioned that this density has the point-wise rooted consistency and a bias that is
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unaffected by the particular structure of this dependence. However, the ultimate goal is to
utilize this as an effect size measure.
Table 4.5 Estimated Arobabilities Along with the Mean Squared Errors
Given in Table 4.5 are the different possible values of the difference (D) and the
estimated probabilities for the data set in Table 2.1 in Chapter 2. The mean squared errors
based on betstrap are also given along with these values.
To fix ideas, note that the estimated probability of the difference being larger than
0 is given by 0.56744 (5.931e-05), where the quantity given in parenthesis is the
bootstrap based mean squared error of this probability. For a randomly chosen subject,
the probability of observing a favorable response under the application of treatment B
relative to treatment A is 0.56744, where the similar quantity based on Mann-Whitney
statistics is 0.57541 (Chen and Kianifard, 2000).
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Table 4.6 Estimated Arobabilities Given Along with 95% Betstrap Confidence Intervals
and Empirical Arobabilities
Similarly one can lek at several possible values of this difference and the
corresponding probability along with its mean squared error. Therefore this approach
gives a more elaborate understanding of the difference D, and the corresponding
betstrap based 95% confidence interval is given in Table 4.5.
Compared to Chen and KKianifard (2000), this approach of effect size measure has
some fundamental difference. In the paper mentioned above, the bledurpressure variable
is assumed to be discrete, but in the present study it is assumed to be continuous
(otherwise the existence of the density cannot be assumed), although the observations are
discrete.
The point-wise 95% betstrap confidence interval of the probability of the
difference value greater than zero is sharper than the confidence interval given in Chen
and KKianifard (2000). Also, based on this study, the corresponding confidence interval of
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the incremental probability of observing a more favorable response from treatment B
relative to treatment A, that is P(Y > X) — Ρ(X > Y), is (0.1044519, 0.1646286), which
does not include 0. Thereby it assures that the difference is significant at the 5% level.
CHAPTER 5
RECEIVER OPERATING CHARACTERISTIC (ROC) CURVE
5.1 Using ROC
Receiver Operating Characteristic (ROC) curve is a plot of `sensitivity' (correct assertion
of disease) versus 'A — specificity' (incorrect positive) of a test. In other words, the
probability of a diseased subject being correctly identified is `sensitivity' and the
probability of a subject without the disease being correctly identified as healthy is
`specificity'. This curve is plotted with respect to the thresholds of discrimination of the
test under discussion, where `sensitivity' is represented along the vertical axis and `Aur
specificity' is represented along the horizontal axis. The concept of ROC has originated
in the signal detection theory but is rapidly gaining acceptance in medical applications,
several branches of engineering and psychometric applications.
References to ROC can be found even in classical regression problem and
discriminant analysis, machine learning and data mining. The following section discusses
some estimation problems in this area.
5.2 ROC from Density
Recall that the ROC curve is the plot of `sensitivity' versus `A — specificity' with respect
to several thresholds of discrimination. If the observations from the diseased group is
denoted as Y and the observations from the healthy group denoted by X, then the standard
way of interpreting the ROC curve is Rap) = FY (FΞ 1 (A — p)) , where the distribution of A
and X are FY and Fx  respectively. The point p is the survival probability of X at a
specified point. Also the survival function of Y, i.e. (A— F) is denoted by i , and the
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inverse of the distribution function of X is denoted as FΞ 1 . Assuming that the cumulative
distribution function is strictly monotone, the value of FΞ1 is unique. Otherwise, if the
strict monotonic property is relaxed then FΞ 1 represents the generalized inverse of the
cumulative distribution function. The functional form of the generalized inverse is given
by the following expression
Obtaining the inverse of a distribution of a function is often quite complicated
from a theoretical point of view, and is expensive from a computational point of view.
Another way of representing the ROC curve is by using the following notation
E, 1 (A p) = c. Hence A— EX  (c) = VEX (c) = p. Thus the same ROC curve plotted as
R (p) against p can be seen as R (p) = E,, (F,A' (A — p)) = FY (c) versus F (c) . In other
words, the above reparametrization helps us identify the ROC curve as the plots of the
survival functions of the variables X and A, where the former represents the healthy group
of subjects and the latter represents the diseased group of subjects.
An important use of ROC curve is to evaluate performances of tests that have a
binary decision space and are based on continuous output. If the ROC curve based on
`test A' goes nearer to the (0, A) point, compared to ROC curve based on another test,
`test B', then `test A' would be a better test compared to `test B'. Along the same lines, a
gold standard test would have a ROC curve going through a point that is very near to the
(0, A) point, which would be denoted as the ideal point from now on. The ROC curve
displays the possible trade-offs between the two kinds of errors (Pepe, A997). So another
important use of the ROC curve is to determine the optimal threshold point in order to
maximize both `sensitivity' and `specificity'. This is same as maximizing `sensitivity'
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and minimizing 'A —  specificity' .
Note that the (0, A) point corresponds to A00% sensitivity and A00% specificity.
Pepe (2003) has detailed discussion on the statistical properties of ROC curve. However,
if there is a test that would randomly classify the subjects into diseased and healthy
group, then the ROC curve based on that test would be the line of equality, represented
The choice of the optimal threshold value that should be used would depend on
many factors such as the associated cost, prevalence of the disease and so on
(Pepe, A997). In the absence of the cost information, one way to chese the optimal point
is to make it closest to the ideal point (van Belle, 2002).
An alternate way an optimal threshold value can be chosen is by chesing the
point as far as possible from the line of equality, which is the ROC of the ad-hoc test, the
test that randomly classifies diseased subjects from the healthy ones. In the following
section, an estimation method of the optimal threshold point would be developed using
the density estimation approach. The results 5.2.A and 5.2.2 would be used for the
estimation algorithm.
The above result was stated without pref in Lloyd (2002).
This simple but useful result can be utilized to obtain the derivative of the ROC
curve at different threshold points. A direct use of the above result is to find the optimal
threshold point based on the maximal vertical distance from the ad-hoc test. Figure 5.A is
an oversimplified picture of a ROC curve, and the point R on the ROC curve is the point
furthest from the line joining (0, 0) and (A, A).
Proof: A general diagram of our problem is given in Figure 5.A. Any point on
the ROC curve is given by R (p). Let the perpendicular distance of an arbitrary point on
the ROC curve from the line of equality be Hap).
Figure 5.1 Finding the optimal point of discrimination using the ROC curve.
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Finding the optimal point for discrimination with respect to the two kinds of
possible errors is a common problem. Ιι logistic regression it is common to come across
a similar problem. For example let a logistic regression equation be given as the
following
Although the πi values can be estimated by fitting the logistic regression curve,
these are essentially the means of the original y, 's. So it remains to predict or estimate
the possible y, values from the obtained estimates of the π ; values. This gives rise to a
discrimination problem and although choosing in the following way is the convention,
this is not necessarily the best choice of π ο  .
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The functional value of the quantity Bap) is Ramp) — p • Therefore, the area of the





area of this triangle and the triangle formed by (0, 0), (A, A) and (A, 0) would be
[Rίρ*) — Ρ * +A ] , which is trivially a lower bound for the area under the ROC curve.
2
Note that the ROC curve is assumed to be concave, and in a practical situation this may
not be the case. In ROC, the stochastically larger variable (P (Y > c) >_ PAX > c), dc) is
usually represented along the vertical axis. However, a concave ROC can be flipped, if
the stochastically larger variable is represented along the horizontal axis. In the original
form of the ROC curve, the represented test has to be at least as good as the ad-hoc test,
therefore the curve stays above the line of equality.
5.3 Estimating the Derivative of ROC and the ARC Using the Density
The following algorithm would be useful to estimate the value of c, the optimal
threshold value. Hence if there is a sample of mixed observations from f and g then their
classification into one group or the other can be done if an individual observation falls on
the right side or the left side of c.
Step 1 Chese an interval of threshold points C, such that this set excludes the points
where either of the density values may be zero. Clearly the optimal threshold point if
exists would belong to this set C.
Step 5 Find the optimal value c, which corresponds tor =A.
Step 6 Since the corresponding pHs are already known, it would be easy to get back to
these original (X ,Y) values.
To find a reasonable error bound for the optimal c *, one can use ε > 0, ε << A such
that C * is the set containing cHs for which the r value is between [A— ε,A + ε] . Figure 5.3
would more clearly illustrate the optimal property of the threshold value c* and also the
fact that the ratio of the density is equal to one at this threshold point.
Figure 5.3 The optimal threshold value c*.
However, the algorithm described in this section guarantees the existence of the
optimal point with an exception of the trivial cases of completely separated densities or
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almost completely identical densities. The uniqueness can be shown for bimodal
distributions with concave ROC curve. If the ROC curve has waves, then the optimal
point can be chosen from several candidate points in way which is analogous to chesing
a global extreme from the candidate local extremes.
5.4 ROC as a Measure of Efficacy
A reparametrized version of the ROC curve is the plot of the two survival functions of the
decreasing threshold values. This version of the curve can be used in the study of effect
size. Following Brumback et al. (2006), one can replace the continuous outcomes of the
diseased population (Y I °) and the healthy population (Y I °) by A and X respectively,
where A and X denote values of the primary efficacy variable for the drugs under study.
The ROC curve in this context would appear to be closer to the ideal point if the outcome
of the more efficacious drug is represented along the vertical axis, assuming that higher
value of the outcome would correspond to better efficacy.
Since the survival function of the two underlying variables are computed at
several possible thresholds c, one can compare the corresponding probabilities, at these
threshold values. On the other hand one can summarize the whole ROC function into a
single value, namely the area under the curve (AUC), which can be shown to be equal to
P(Y > X) . So the ROC curve gives the comparison of the values P( A > c)
and Ρ (X > c) for different values of c and the area under it is an estimate of the
quantity PAY > X) .
A function closely related to the reparametrized version of the ROC curve is the
vertical shift function (A) given by
where (A Ι °) has the distribution E,, and (Y Ι °) has the distribution F . Here and
' denotes the two underlying properties of the populations being considered. For
example ' could be the placebo group and c, the group where the drug under study
has been administered. The relation between the ROC curve and the vertical shift
function defined above is given in Ghost and Toward (2007)
Here R(p) is the ROC curve, and the function A(.) denotes the vertical shift function.
For some early development of the shift functions in the context of two sample problems
see Docks (A974).
Hence, the shift function can also be utilized in the effect size estimation. For
example, this can help in the estimation of the area under the ROC curve under different
threshold values. This in turn would be useful to identify the superior drug when there are
two drugs under study.
The following two results 5.4.A and 5.4.2 are special cases of the results by Ghosh
and Tiwań (2007). Their result is based on Generalized Rank Set Samples aGRSS) and in
the present context is simplified for the case of Simple Random Sample aSRS). These two
results given below can be effectively used for the estimation of the point-wise variance
of the ROC curve and then utilized to create a confidence band for the ROC curve. This
can also be extended in finding a confidence interval for the ES obtained as the area
under the ROC curve.
Result 5.4.1 If two Simple Random Samples (SRS) of size m and n are collected
from two populations, where the population ROC curve is denoted by R, then the
empirical ROC curve given by R has the following asymptotic property
Here p, q lies in the open interval (0,A) , p n q denotes the minimum of p and q.
fX and f are the densities corresponding to the distributions E and F .
Therefore if we call the expression in (5.A) as K(p), then a point-wise confidence
band of the ROC curve can be constructed inverting the above relations. This confidence
interval is given in the following equation
standard normal percentile with area to the right equal to α / 2.
Note that the empirical ROC curve ( R ) mentioned above is computed from the
raw data just like the empirical distribution is computed. The empirical ROC of the
example of the double-blind drugs introduced in chapter 2 is given in the following
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Figure 5.4. The horizontal axis represents the drug A and the vertical axis represents the
drug B .
EmpirEcal ROC curve and Confidence Band
Figure 5.4 Empirical ROC curve and a 95% confidence band.
Based on the method described in the beginning of this chapter (see Figure 5.2),
an estimate of the area under the empirical ROC curve is computed. The value of the
probability corresponding to the optimal point of separation is given by 0.77966A, the
notation for this point is p *. The corresponding ROC curve value Rap *) is given by
0.949A525. Therefore the estimated area under the ROC curve given by
comparison of the estimates from different methods. The same example of the double-
blind drugs is used in this effect size measurement.
* 	 Based on the smoothed density estimate (See Chapter 4).
** Based on optimal point of separation (See earlier this chapter).
t 	 Based on numerical Riemann-Stieltjes integration.
° 	 Based on Empirical distribution function.
Riemann integration deals with finding the area under a curve f(x) in a bounded
interval [a, b], where this interval is divided into finite number of subintervals n. Then
This way the area is computed by the means of rectangles.
A more general case of the Riemann integration is the Riemann-Stieltjes
integration (see Apostle A990). This involves two functions. In the present discussion,
these two functions are p (c) and R (p (c)) respectively. This would deal with the sum
of the form Σ R(tk )Δpk (Recall that the original variable c, the threshold value, is not
k=1
represented on the ROC curve). To get an estimate of the ES, the mean of the upper sum
and the lower sum of the integral is computed using a numerical Riemann-Stieltjes
integral.
5.5 Numerical Results
The confidence interval of the ROC curve based on the expression given in the equation
(5.2) is given below (Table 5.2). The reported values of p and R(p) are the empirical
values computed from the data set given in table 2.A. The confidence interval is the SRS
based result simplified from the general result for GRSS, Ghost and Tiwari (2007).
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The Confidence interval of the empirical ROC curve is reasonably sharp. Note
that it is actually a point wise confidence band based on the standard deviation of the
ROC curve evaluated at a grid of points using the Result 5.4.2.
Table 5.2 Confidence Interval of ROC Curve
The estimating algorithm for the optimal threshold applied to the combination of
normal variables yields the following results. Samples of size m, where m denotes 200 or
2000, are drawn from the Y and X densities and C* points are estimated from the fitted
densities (see section 5.3 in the current chapter). Reported values are the median
estimates obtained from 40 replications of the process. Given in parenthesis are the
median absolute deviations of the estimates.
Table 5.3 Estimated Optimal Threshold Value c*
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The noteworthy observation here is that the estimates are reasonably stable even
when densities are estimated using fewer numbers of data points, although the mean
squared errors are relatively higher for the small sample size.
CHAPTER 6
CONCLUSIONS AND FUTURE STUDIES
The major finding of this study is the fact that information from datasets with heavy
dependence can be extracted with the use of tools provided. Also, density estimation
methods, and particularly kernel smoothing can be used in efficacy measurement. The
estimated density has the nice rooted consistency and yield smaller MISS compared to
the density estimate computed from independent data. Both have the same form of the
bias function.
Confidence intervals based on bootstrap and double bootstrap methods are quite
effective in the context of finite or infinite dimensional problems like density estimation.
Given that in the real world one has to work with smaller datasets which are often
imperfect and dependent, this study is an example where heavy computing can certainly
overcome some of these shortcomings in an effective way. Efficacy measurement is a
problem that is constantly under focus in clinical studies. In the current age of advanced
computing, both the problem and the approaches towards its solution can be addressed
through developing efficient algorithms and programs.
There are many possible ways the current study can be extended in different
directions:
(1) Theoretical and numeric implementation and development of double bootstrap
in dependent data.
(2) How to find a theoretical estimate of the density when the D data with the
variance covariance matrix = I O P + (J — I) O Ρ is either known or
estimable.
(3) How dependent density estimation can be utilized in non-parametńc
regression (smething) methods in a dependent set up.
66
67
(4) Generalize simulation study to include normal mixture densities.
(5) Apply the nonparametric Bayesian method to estimate the ROC curve using
Iixture of Dirichiet Arocess (MMDP) priors. This can be done by proceeding as
in Erkanli et al. (2006).
(6) Some asymptotic results on the general form of the kernel covariant. For
example if the underlying distribution is normal, closed form expressions can
be obtained for the covariance after the application of the kernel function.
Similarly, assuming known continuous distributions of the underlying
densities would give us a comparison of the results.
APPENDIX
SOURCE CODES
Some selected source codes written in R are included in this section. R is the free version
of the S/Splus software (Ihaka and Gentleman, A996 ). The R packages along with
relevant packages are available for download for free from the comprehensive R network,
http://cran.r-project.org/.
The R version 2.3.A is used for the present study along with the editor Tinn-R version
A.A7.2.4, available for download from the following website
http://www.sciviews.org/Tinn-Ri.
Each of these codes is linked with one or more chapters. There are several lines of
comments included in each code to clearly explain the objective.
The following program is used to compute the UMVU estimator in the





# END OF PROGRAM 1 #
The following code is used to do the Monte Carlo simulation of the estimator, by
repeatedly calling the above routine. The outputs are recorded in a file and saved for post
processing.
The following program calculates the betstrap density estimator from the dataset
introduced in Chapter 2 and used repeatedly to illustrate many of the methods that is
developed in the current study.
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dDD 	 = density(DD, bw="bcv", kernel="epanechnikov", from=-8,to =8,
n=1024);
Z 	 = dnorm(dxy$x, mean=1, sd=sgrt(2), log = FALSE)
part=seg(1,1024,by=20);
plot(Z[part],cex=.75,1ty=l,type="b",xaxt="n",ylab="density", xlab="x
values",mainladensity estimates compared with the real density",
ylim=c(0,.4), col="blue", pch=4,lwd=2)
# cbind(part,dxy$x[part])
axis (1, at=c (1, 10, 20, 30, 39, 49) , labels=c (-8, -5, -2, 1, 4, 7) , las=l)
points(dDD$y[part], collared", pch=15, cex=.75,1ty=2, typelab",lwd=2)
points(dxy$y[part], callable", pch=24 , cex=.75,1ty=3, type"b",lwd=2)
leg.txt=c("real tensity", "dens-est index", "dens-est deep");
legend(0.3, leg.txt, col = c("black", "red", "blue"),
pch=c(4,15,24),lty=c(1,2,3),
lwd=c(2,2,2))
# Read the original data #
bp=read.csv("L:/courses/research/clinical/data_bρ_a_b.csv ",
header=TRUE)




dd= mat.or.vec(512,(Β+1)) # Declare the place holding variable dd
# Fill the last column with the x values
dd[,(B+1)]=density(D, bw="nrd0",kernel="epanechnikov", n=512,from=-
80,to =80)$χ
# Now start the bootstrap resembling
for (i in 1:B)
{
DD = sampled, replace=T)
as = density, bwlanrd0",kernel="epanechnikov", n=512,from=-80,to
=80)
# Density has been evaluated at the fixed x values #
dd[,i]=ss$y # Save just the y
}
V = seg(-40,40,by=5)
DD= rat, or .Dec (17, B)
for(i in 1:B)
{ DD[,i]=apply(as.array(V),1,PyLTC,dd[,B+l],dd[,i])}
I 	 = apply(as.array(DD),l,mean)
# SS 	 = apply(as.array(DD),1,var)
ISE 	 = apply ((DD-I) ^2, 1, mean)
# The probabilities of the values given with the MMSE's
cbind(V, round(1-I,digits=5), round(MSE,digits=8))
# Bootstrap 95% CI of the estimated probabilities.
apply(as.array(DD),l,quantile, ρrob=c(0.025,0.975))
# END OF PROGRAM 3 #
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The following program is self explanatory. The ultimate goal of this program is to
utilize the density estimate and find the efficacy measure following the methods
described in Chapter 4.
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# File = paste("D:/DATA/PyLTC/BOOTdensity_ ",1:B,".txt", seep=") # home
File = paste{"C:/DATA/ΒΟΟΤdensity_",l:Β,".txt", seep=") # NJIT
for (i in 1:B)
{
DV = sample(xy, replace=T)
dXY = density(XV, bwlabcv", kernellaepanechnikov",from=lowxy,
to=hixy,n=nn)
dXY=cbind(dXV$x,dDV$y) # Save just the x and yes
write.table(dXY, file=File[i]) # Use write table to write in the
files
}
# READ IN NOW
a= mat.οr.vec(512,B) # Declare the place holding variable dd
for (i in 1:B)
{
tt= read.table(File[i]) # Read the tables in this temp var tt
dd[,i]=tt$V2 	 # Save only the evaluated density
}
rm(tt)# Now just delete tt and retain a.
# This is our density it would have
# the x values, median values/ 2.5%
# and 97.5% values &var; 5 columns
our_dent 	 = mat.or.vec(512,5)
our_dent [, 1 ] = dXY [, 1 ]
our_den] 	 = apply(a, median);
our_den] 	 = apply(dd,l,var);
# our_den[,c(2,5)] 	 = cbind(apply(a median) ,apply, l,var))
for (i in 1:512)
{
our_den[i,3] = guantile(a[i ] ,probe=. 025);
our_den[i,4] = guantile(dd[i,],prob=0.975);
}
# par(cex=0.7, cex.axis=1.2, cex.lab=1.2, cex.main=l.2)
plot(our_den{,2], pch=e+e, ylim=c(0,.035))
points (our_dent [, 3], collared", pchla^")
points(our_den[,4], col=''blue", Bchla*")
#points(our_den[,2]+20000*our_den[,5], col=grey80", Bch="@", typelab")
#ρoints(our_den[,2]-20000*our_den[,5], collakhaki", Bchla%", typelab")
CC = seq(-20, 60, by=5)
PyLTC (CC [ 1 : 3 ] , our_dent [ , 1]  ,a[,  1 ] )
sapply(t(CC),PyLTC,X = our_den[,1],V=a[,1])
myfun <- function(X,y) {y[which.min(abs(X-y))]}
apply(as.array(X), myfun, y = our_dent [, I])
# rm(B,bp,D,dXY,File,a,our_den)
# END OF PROGRAM 4 #
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The following program will be used to compute the covariance kernel of the
Gaussian process under a specific point F. The relevant theory can be found in Chapter 5.
Note that this is a three step transition, once from GRASSERS to SRS, then from the
shift function to the ROC, then both the evaluation points for the kernel is taken to be the
same. In other words, KRSRS(p, q) is taken to be KR,sRS (P, p). See section 5.4 in
Chapter 5 for more information.
# END OF PROGRAM 5 #
The following function will compute the point wise confidence interval for the
empirical ROC curve based on the covariance kernel explained above. To change the
coverage probability only the value of the quantize function from the standard normal
distribution needs to be changed. These results just like the results used in the above
program are given in section 5.4 of Chapter 5.
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